NON SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests whether giving chemotherapy plus an immunotherapy drug (cemiplimab) before surgery can help people with stage 3 lung cancer that has spread to certain lymph nodes. About 21 adults will receive four cycles of the drug combo, then have surgery to remove the cancer.…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 26, 2026 04:50 UTC
-
Virus therapy takes on lung cancer after standard treatment fails
Disease control Recruiting nowThis study tests a new approach for people with advanced non-small-cell lung cancer whose disease has worsened after initial chemotherapy and immunotherapy. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Blood test hunts hidden lung cancer cells to stop return
Disease control Recruiting nowThis study is for people with early-stage non-small cell lung cancer. After standard treatment, a blood test checks for leftover cancer DNA, which raises the risk of the cancer coming back. If the test is positive, participants receive the drug durvalumab to try to lower that DNA…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Lung cancer survivors may breathe easier with pulmonary rehab, new study hopes to prove
Symptom relief Recruiting nowThis study tests whether a supervised exercise and breathing program (pulmonary rehabilitation) can improve shortness of breath and quality of life in people with advanced non-small cell lung cancer. Half of the 85 participants will receive 8 weeks of rehab, while the other half …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC
-
New radiation technique aims to protect heart in thoracic cancer patients
Knowledge-focused Recruiting nowThis study tests if a newer, MRI-guided radiation therapy (MRgART) is gentler on the heart than standard radiation for people with lung, esophageal, or other chest cancers. About 60 adults will receive radiation and have their heart function measured via MRI and blood tests. The …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 26, 2026 04:55 UTC
-
Lung cancer study tracks immune response after standard treatments
Knowledge-focused Recruiting nowThis study looks at how the immune system responds to immunotherapy after chemo-radiation in people with stage III non-small cell lung cancer that cannot be removed by surgery. Researchers will review medical records of 50 patients to see how long they live or stay cancer-free. N…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC